by Peter Ciszewski | Nov 6, 2020
Andrew Krivoshik, MD, PhD, Oncology Therapeutic Area Head at Astellas Pharma talks about Be R/Ready, a resource for patients with relapsed or refractory acute myeloid leukemia (AML) and their physicians. AML is a rare aggressive cancer of the blood and bone...
by Peter Ciszewski | Nov 4, 2020
Justin Hopkin, MD, Board Chair for the National Niemann-Pick Disease Foundation (NNPDF) talks about the changes their foundation has made to keep their families connected and informed during the Covid-19 pandemic. Dr. Hopkin is the father of a child with Acid...
by Peter Ciszewski | Nov 3, 2020
Carri Levy, Producer of Behind the Mystery, talks about the origins of the show as it celebrates its 100th segment. Behind the Mystery is a recurring segment on Lifetime Channel’s The Balancing Act that is devoted to rare and genetic diseases. Each episode...
by Peter Ciszewski | Nov 2, 2020
Eric Jonasch, MD, Professor, Department of Genitourinary Medical Oncology at MD Anderson Cancer Center, discusses data presented on MK-6482 for the treatment of renal cell carcinoma associated with von Hippel-Lindau disease. Von Hippel-Lindau disease is a...
by Peter Ciszewski | Oct 30, 2020
John Kuruvilla, MD, from the Princess Margaret Cancer Centre summarized the latest quality of life data from the Phase III KEYNOTE-204 Hodgkin lymphoma study comparing pembrolizumab to brentuximab vedontin. The study involved adults with relapsed or refractory...
